SICEM 2024

Satellite symposium 1 (K) [Daewoong Pharmaceutical] Day 1, Thursday, April 11, 19:30-20:30 / Room 4 (B2)

Chairpersons : Ie Byung Park (Gachon University, Korea), Sung-Hoon Kim (Mizmedi Hospital, Korea)

	19:30-20:20	Opening a new roadmap of diabetes treatment based on CGM and data connect system Jae Hyoung Cho (The Catholic University of Korea, Korea)
	20:20-20:30	Discussion

Satellite symposium 2 (K) [Hanlim] Day 1, Thursday, April 11, 19:30-20:30 / Room 5 (4F)

Chairpersons : Kyungwan Min (Eulji University, Korea), Hyeong-Kyu Park (Soonchunhyang University, Korea)

	19:30-19:55	Treatment strategy for dyslipidemia with diabetes, focusing on pitavastatin Soon Hyun Park (Daejeon Endo Internal Medicine Clinic, Korea)
	19:55:20:20	Personalized treatment for diabetes: criteria for selecting medication by patients Jae-Han Jeon (Kyungpook National University, Korea)
	20:20:20:30	Discussion

Satellite symposium 3 (K) [Boryung] Day 2, Friday, April 12, 19:30-20:30 / Room 4 (B2)

Chairpersons : Sung Woo Ha (Dr Ha's Internal Medicine, Korea), Hun-Sung Kim (The Catholic University of Korea, Korea)

	19:30-19:55	TRU-BUDDY combination therapy: benefits for beta cell & insulin resistance Chang Hee Jung (University of Ulsan, Korea)
	19:55:20:20	TRU-BUDDY combination therapy: benefits for diabetic complications Dughyun Choi (Soonchunhyang University, Korea)
	20:20:20:30	Discussion

Satellite symposium 4 (K) [Novo Nordisk] Day 2, Friday, April 12, 19:30-20:30 / Room 5 (4F)

Chairpersons : Ho-Young Son (The Catholic University of Korea, Korea), Seok O Park (Baksem Internal medicine Clinic, Korea)

	19:30-19:55	Improved glycemic control and patient outcomes: switching from basal insulin to IDegLira in uncontrolled type 2 diabetes patients Sang Yong Kim (Chosun University, Korea)
	19:55:20:20	Clinical patients benefits of IDegLira prescription: insights from the latest real-world evidence Shin Ae Kang (Yonsei University, Korea)
	20:20:20:30	Discussion

Scientific program